Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€0.24

€0.24

30.390%
0.055
30.390%
-
 
27.03.24 / Frankfurt WKN: A0DNJ3 / Name: PharmAust / Stock / Pharmaceuticals / Micro Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

PharmAust Ltd. Stock

PharmAust Ltd. dominated the market today, gaining €0.055 (30.390%).

Pros and Cons of PharmAust Ltd. in the next few years

Pros
?
S********** s********
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of PharmAust Ltd. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
PharmAust Ltd. 30.390% 22.280% 27.568% 349.524% 283.740% 310.435% 1375.000%
Biotec Pharmacon ASA - 6.624% -0.598% -26.008% -30.694% -64.255% 494.048%
Immutep Ltd. -2.680% 0.000% 5.825% 42.298% 4.808% -22.143% 67.692%
TALI Digital Ltd. - 0.000% 0.000% 0.000% 0.000% -97.917% -90.000%

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-05-30

PharmAust, a pharmaceuticals company, has shown mixed financial results according to the data provided. As a financial analyst, it is essential to examine the overall trends observed in their financial statements, including balance sheets, cash flow, and income statements.

*Pros: * 1. Positive Net Working Capital: PharmAust displayed a positive net working capital over the last three years, reaching $2,564,991 AUD for the year ending June 2022. This indicates that the company has enough short-term assets to cover its short-term liabilities.

Cash Position: PharmAust's cash position has been relatively stable, even though it experienced a decrease in the period ending June 2022. The company maintains a cash balance that allows for flexibility in funding its operations, expansion, and other potential business ventures.